Trials / Completed
CompletedNCT02137538
Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole
Randomization to Letrozole vs. Anastrozole in Short Pubertal Males
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- Male
- Age
- 10 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine if there are differences in the final height or hormone profile of short pubertal boys placed on different forms of aromatase inhibitor now routinely used to increase stature: Anastrozole and Letrozole. It also should determine if there are differences in the side effect profiles of the two drugs to be used.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Letrozole | |
| DRUG | Anastrozole |
Timeline
- Start date
- 2009-11-18
- Primary completion
- 2018-06-05
- Completion
- 2018-06-05
- First posted
- 2014-05-14
- Last updated
- 2021-07-15
- Results posted
- 2021-07-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02137538. Inclusion in this directory is not an endorsement.